Comparison of American mink embryonic stem and induced pluripotent stem cell transcriptomes by Aleksei G Menzorov et al.
RESEARCH Open Access
Comparison of American mink embryonic stem
and induced pluripotent stem cell transcriptomes
Aleksei G Menzorov1,2*, Natalia M Matveeva1, Marios N Markakis3,4, Venyamin S Fishman1, Knud Christensen4,
Anna A Khabarova1, Inna E Pristyazhnyuk1, Elena A Kizilova1,2, Susanna Cirera4, Razvan Anistoroaei4,
Oleg L Serov1,2
From The 7th International Young Scientists School
Novosibirsk, Russia. 22-25 June 2015
Abstract
Background: Recently fibroblasts of many mammalian species have been reprogrammed to pluripotent state
using overexpression of several transcription factors. This technology allows production of induced pluripotent
stem (iPS) cells with properties similar to embryonic stem (ES) cells. The completeness of reprogramming process is
well studied in such species as mouse and human but there is not enough data on other species. We produced
American mink (Neovison vison) ES and iPS cells and compared these cells using transcriptome analysis.
Results: We report the generation of 10 mink ES and 22 iPS cell lines. The majority of the analyzed cell lines had
normal diploid chromosome number. The only ES cell line with XX chromosome set had both X-chromosomes in
active state that is characteristic of pluripotent cells. The pluripotency of ES and iPS cell lines was confirmed by
formation of teratomas with cell types representing all three germ layers. Transcriptome analysis of mink embryonic
fibroblasts (EF), two ES and two iPS cell lines allowed us to identify 11831 assembled contigs which were annotated.
These led to a number of 6891 unique genes. Of these 3201 were differentially expressed between mink EF and ES
cells. We analyzed expression levels of these genes in iPS cell lines. This allowed us to show that 80% of genes were
correctly reprogrammed in iPS cells, whereas approximately 6% had an intermediate expression pattern, about 7% were
not reprogrammed and about 5% had a “novel” expression pattern. We observed expression of pluripotency marker
genes such as Oct4, Sox2 and Rex1 in ES and iPS cell lines with notable exception of Nanog.
Conclusions: We had produced and characterized American mink ES and iPS cells. These cells were pluripotent by
a number of criteria and iPS cells exhibited effective reprogramming. Interestingly, we had showed lack of Nanog
expression and consider it as a species-specific feature.
Background
Recently mouse and human adult and embryonic fibro-
blasts (EF) have been reprogrammed into pluripotent state
by overexpression of only four transcription factors [1-3].
At present, induced pluripotent stem (iPS) cells have been
derived from somatic cells of mammalian species such as
primates [4-7], rat [8], prairie vole [9], rabbit [10],
dog [11-16], pig [17], horse [18], sheep [19], cow [20], goat
[21] and buffalo [22]. In addition, iPS cells have been pro-
duced from endangered species, e.g. rhinoceros [7] and
snow leopard [23]. Mouse and human iPS cells are very
similar to embryonic stem (ES) cells produced from
blastocyst inner cell mass [24]. Apart from extensively
studied mouse and human iPS cells, little is known
about characteristics of iPS cells of other mammalian
species. Additionally, ES cells are produced from a lim-
ited number of species and their pluripotent state is
rarely well characterized. This complicates comparison
between ES and iPS cells. So far, there are no reports of
iPS cell derivation from somatic cells of any mustelid
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species. The aim of the current research is producing
mink ES and iPS cells to assess reprogramming comple-
teness by comparing gene expression profiles of mink
EF, ES and iPS cells.
We report generation of American mink pluripotent
ES and iPS cells. Transcriptome analysis shows efficient
EF genome reprogramming. Pluripotent stem cells
express key pluripotency markers with notable exception
of Nanog.
Results
ES and iPS cell derivation
American mink ES cell line MES12 used in this study was
previously described by our group [25]. By using the same
protocol we have generated an additional set of mink ES
cell lines. Twelve mink morulas and early blastocysts were
plated on feeder cells, and in a total of 10 ES cell lines were
produced. As in the previous series, they were designated
as MES (MES20 - MES29). Unlike mouse ES cells, mink
ES cells contain peripheral visible granules and form flat
monolayer colonies of epithelial-like morphology [25,26].
To produce iPS cells from primary mink EF we used the
following human reprogramming transcription factors:
OCT4, SOX2, C-MYC and KLF4. To facilitate reprogram-
ming process we supplemented culture medium with val-
proic acid, an epigenetic modifier that inhibits histone
deacetylases. Two weeks after first lentiviral transduction
of EF we observed many colonies with different morphol-
ogy. Based on mink ES-like morphology we selected and
picked up 25 colonies. From these primary colonies 22 iPS
cell lines were successfully produced. We designated them
as iNV (iNV1 - iNV22). Morphology of iPS cell line iNV11
colony is shown in Figure 1a.
We assessed the efficacy of colony formation in a
separate experiment with the same conditions as above.
We observed 722 colonies (1.2% of initial 6 × 104 trans-
duced cells) on day 11 after transduction of mink EF.
Most of them had mink ES-like phenotype.
Cytogenetic analysis
We randomly selected 6 out of 10 ES cell lines and 11 out
of 22 iPS cell lines for the analysis. The results of the cyto-
genetic analysis are shown in Table 1. Five ES cell lines
were XY, and MES25 was XX. All analyzed iPS cell lines
were XY as they were produced from EF derived from a
single male embryo. All analyzed pluripotent cell lines
with the exception of MES20 had diploid modal chromo-
some number. We consider it as an indication of karyo-
type stability. In MES20 64.3% of cells had tetraploid
chromosome number. Tetraploidization of pluripotent
cells frequently happens in vitro for human and mouse ES
cells and thus some percentage of tetraploid cell lines
could be considered as normal [27]. A metaphase plate
and a karyotype of iNV11 are presented in Figure 1b-c.
X-inactivation analysis
Female pluripotent cells have both X-chromosomes in
active state. One of the markers of inactive X-linked
chromatin modifications is histone H3 trimethylated at
lysine 27 (H3K27me3) [28,29]. Control female mink EF
had 82.3% (n = 96) cells positive for H3K27me3 as
expected. In the only XX pluripotent cell line, MES25,
87% (n = 285) of the cells were negative for inactive X-
linked chromatin marker. Most of the positive cells
were situated at the borders of ES cell colonies and
might represent differentiation (Additional file 1). Thus,
MES25 has both X-chromosomes in active state con-
firming its pluripotency.
Generation and analysis of teratomas
To analyze the pluripotency of ES and iPS cells we used
the in vivo teratoma formation assay. The summary of
teratoma analysis data is presented in Table 2. Cell
types in the individual teratomas are presented in Addi-
tional file 2. Teratomas generated from ES cell lines
MES22, MES24 and MES29, and iPS cell lines iNV7,
iNV11, iNV19 and iNV20 had most or all analyzed cell
types representing three germ layers (ectoderm, endo-
derm and mesoderm). Thus, we consider these cell lines
pluripotent. Representative cell types in MES29, iNV7
and iNV11 derived teratomas are shown in Figure 1f-n.
These three cell lines and the previously characterized
MES12 [25] were chosen for the transcriptome analysis.
Transgene silencing analysis
Transgenes inserted into pluripotent stem cells with
viral vectors are usually silenced [28,30,31]. We per-
formed analysis of the human transgene silencing in iPS
cell lines iNV7 and iNV11 by RT-PCR using human
specific primers (Additional file 3) for OCT4, C-MYC,
KLF4 and SOX2. Human transgenes KLF4 and C-MYC
were silenced, as no product was visible in the agarose
gel with the exception of a slight band in the iNV7 line
for C-MYC (Figure 1d-e). In addition, we showed C-
MYC and KLF4 transgene silencing for iPS cell lines
iNV5, iNV15 and iNV20 (data not shown). In the case
of SOX2 and OCT4 genes, due to their high sequence
conservation between human and mink in the coding
region, we were not able to design human specific pri-
mers. Therefore, we have no information about the
silencing of the SOX2 and OCT4 transgenes. We can
thus conclude that the human transgenes are mostly
silenced in the mink iPS cell lines.
Quantitative real-time PCR (qPCR) results
We verified expression of several mink genes by qPCR
(Additional file 4 Additional file 5). We found significant
differences between the five cell lines for the gene
expression: Oct4 (P = 2.00E-08), Nanog (P = 3.00E-08),
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Gdf3 (P = 8.00E-08), Sox2 (P = 1.63E-05) and Nestin (P
= 0.0351). Interestingly, looking at the pairwise post
comparisons (Additional file 6 Figure 2a), we can see
that gene expression varies between pluripotent cell
lines. As expected, the mink EF show a pattern of
expression very different from the pluripotent cell lines.
Transcriptome analysis
To assess completeness of reprogramming in mink iPS
cells we compared transcriptomes of ES cells, iPS cells
and EF. We selected cell lines for transcriptome analysis
based on cytogenetic analysis and teratoma formation
test. For transcriptome analysis all cell lines were cul-
tured for two passages in three independent replicates.
Mink EF were collected on passage 7, ES cells lines
MES12 and MES29 on passages 21 and 25, respectively,
iPS cell lines iNV7 and iNV11 on passages 10 and 11,
respectively. To eliminate contamination with mink EF
transcripts ES and iPS cells were grown on mouse
strain CD-1 feeder cells. We produced between 4.0 and
Figure 1 iPS cell morphology, karyotype and examples of cell types in teratomas developed from mink ES and iPS cells . a -
morphology of iNV11 iPS cell line colony; b - iNV11 metaphase plate; c - iNV11 karyotype; d - expression of human transgene C-MYC; e -
expression of human transgene KLF4; examples of representative cell types in teratomas formed from pluripotent cell lines: f - epidermal
epithelium with hair follicle; g - gut-like epithelium; h - bone, adipose and hematopoietic tissues; i - rosettes of neural epithelium; j - gut-like
epithelium; k - connective and adipose tissues; l - rosettes of neural epithelium; m - hepatocytes; n - erythropoietic tissue.
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23.9 million reads for each cell line replicate (see Addi-
tional file 7).
Hierarchical clustering, as well as principal component
analysis (PCA) of transcriptome data, shows a sharp
contrast between EF and pluripotent cells (Figure 3a-b).
80% of all differences in expression levels observed
between cell lines can be explained by difference
between differentiated and pluripotent cells, whereas
only 13% of dissimilarities reflect difference between ES
and iPS cells (Figure 3b). This result clearly indicates
that the reprogramming process results in cells that lose
most of EF signature genes and are very similar to the
pluripotent ES cells.
The observed slight difference between ES and iPS cells
might reflect incomplete reprogramming, a phenomenon
well known for mouse and human iPS cells. A common
source of incomplete reprogramming is so-called
“somatic memory” determined as expression of certain
genes in iPS cells on a level of original somatic cells [32].
To study “somatic memory” in iPS cells we decided to
perform detailed analysis of genes that are differently
expressed in EF and ES cells. We annotated 11831 con-
tigs out of 30490, generated by Trinity. Among them we
identified 6891 unique genes and found 3201 showing
significant difference in expression between EF and either
MES12 or MES29 cells (Additional file 8). Of these, the
Table 1 Cytogenetic analysis of ES and iPS cell lines.
Cell line Sex chromosomes 29 chromosomes (%) 30 chromosomes (%) 31-32 chromosomes (%) Tetraploid cells (%) N
MES20 XY 4,8 23,8 71,4 21
MES22 XY 17.6 50.0 14.7 17.6 34
MES24 XY 12.0 68.0 12.0 8.0 25
MES25 XX 9.4 84.4 6.2 32
MES27 XY 6.7 79.9 6.7 6.7 30
MES29 XY 14.3 74.3 5.7 5.7 35
iNV3 XY 21.9 75.0 3.1 32
iNV5 XY 7.1 85.8 7.1 28
iNV6 XY 21.0 67.9 3.6 7.1 28
iNV7 XY 87.1 3.2 9.7 31
iNV9 XY 12.1 78.8 9.1 33
iNV11 XY 15.1 72.7 3.1 9.1 33
iNV13 XY 16.1 80.6 3.2 31
iNV15 XY 9.4 81.3 3.1 6.2 32
iNV18 XY 11.5 77.0 3.8 7.7 26
iNV19 XY 12.0 80.0 8.0 25
iNV20 XY 9.1 60.6 8.8 20.6 33
N - number of metaphase plates, bold font - percentage of cells with modal chromosome number
Table 2 Summary of histological analysis of teratomas formed after injection of ES and iPS cells into immunodeficient
mice.
iNV3 iNV5 iNV6 iNV7 iNV11 iNV13 iNV15 iNV19 iNV20 MES20 MES22 MES24 MES29
primitive neuroepithelium + + + + + + + + + +
keratinized epithelium + + + + + + + + + +
melanocytes and pigmented epithelium +
connective tissue + + + + + + + + + + + + +
cartilage + + + + +
bone + + + + + + + + + + +
muscle + + + + + + + + + +
adipose tissue + + + + + + + + + + + +
erythropoietic tissue + + + + + + + + + + +
lymphoid tissue + + + + + + + + + +
ciliated epithelium + + + + + +
gut-like epithelium + + + + + + +
glandular epithelium + + + + + + +
hepatocytes or pancreocytes + + + + + + + + +
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majority of genes were expressed at the same level in
iPS and ES cells, thus being correctly reprogrammed.
List and examples of such genes are presented in
Additional file 9, Figure 2b (Oct4, Sox2 and Rex1) and
Figure 3c. Some genes show intermediate expression
pattern, i.e. characterized by expression level between
EF and ES cells. A small number of genes were not
reprogrammed, displaying EF-like expression pattern in
iPS cells with expression level significantly different
from both MES12 and MES29 cell lines (Figure 3)d.
Finally, few genes do not fall into correctly repro-
grammed, intermediate or not reprogrammed categories.
We designed these genes as “novel”, since they show a
novel expression pattern in iPS cells, different from
both EF and ES cells (Additional file 10). In contrast to
genes from intermediate category, the expression level of
Figure 2 Expression levels of several genes of interest in mink EF, ES and iPS cells based on transcriptome analysis and qPCR. a -
results of qPCR for Oct4, Sox2, Gdf3, Nestin (Nes) and Nanog; b- expression levels of Oct4, Sox2, Rex1, Nanog, Cer1, Otx1, Gata6 and Gapdh genes
in mink pluripotent cells and EF. The vertical axis represents counts determined for each sample by transcriptome analysis.
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these “novel” genes does not lie between levels of EF and
ES cells, suggesting that unexpected expression of these
genes is not due to incomplete activation or repression
of respective promoters during reprogramming process,
but rather is a result of some reprogramming mistakes.
The lists and number of genes with different patterns of
reprogramming are presented in Additional file 8 and
Table 3.
Figure 3 Transcriptome gene expression analysis. a - hierarchical cluster dendrogram based on the expression levels of 100 genes with a
highest variance between samples; b - principal component analysis of expression based on the same set of genes as in a. The horizontal axis
represents the first principal component of variation - a projection of the array data representing the maximal variance among them (80% of
total variance between samples). The vertical axis represents the second principal component of variation (13% of total variance); c - example of
heat-map presentation of gene expression profiles of correctly reprogrammed genes in mink EF, ES and iPS cells. Each row of the heat-map
corresponds to one gene, and expression levels are shown using color-code (blue color represents the lowest expression level, red color - the
highest); d - example of heat-map presentation of gene expression profiles of not reprogrammed genes in mink EF, ES and iPS cells.
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Discussion
We have produced American mink ES and iPS cell lines.
Their pluripotency was confirmed by teratoma forma-
tion test. We have observed silencing of two of four
transgenes in analyzed iPS cell lines. That is in line with
reports on transgene silencing in mouse and human iPS
cells [28,30,31]. American mink represents one of a few
species for which both ES and iPS cells were obtained.
This had allowed us to address several important ques-
tions. One of them is completeness of somatic cell
reprogramming, whether genes of EF origin are effec-
tively reprogrammed to pluripotent state in iPS cells.
Another question refers to the nature of the pluripotent
state in the American mink ES and iPS cells, naïve or
primed [33,34].
We had shown that the majority of genes were cor-
rectly reprogrammed (Table 3). About 400 genes were
not reprogrammed or have “novel” expression pattern in
iPS cells. That is comparable with data on human iPS
cells where approximately 600 genes were not repro-
grammed in iPS cells compared to ES cells [32]. In
another study, it was shown that in 12 human iPS cell
lines an average of 550 genes were not reprogrammed
compared to ES cell reference. It should be noted that
ES cell lines differed in gene expression. In the same
study an analysis of 20 ES cell lines revealed on average
387 differentially expressed genes in each line compared
to ES cell reference [24]. Thus, such number of differen-
tially expressed genes could be attributed to “normal”
gene expression fluctuations or differences. In general,
we conclude that the majority of the genes in both ana-
lyzed iPS cell lines were effectively reprogrammed.
The second question concerns the status of pluripo-
tency in mink cells. Recently, pluripotent cells were
divided into two categories: naïve and primed, distin-
guished by colony morphology, pattern of gene expres-
sion and other features [33,34]. Mouse ES cells are
considered naïve while human ES cells resemble primed
epiblast stem cells. The appliance of 2i inhibitors (MEK
inhibitor PD 0325901 and GSK3 inhibitor CHIR 99021)
was shown to switch the pluripotent state from primed
to naïve. Among species with reported iPS cell deriva-
tion the closest to N. vison is dog, Canis familiaris,
order Carnivora. Interestingly, in canine ES [35-39] and
iPS cells [11-16] different research groups were able to
observe both morphological cell types, although their
pluripotent state was not identified. However, it should
be noted that only three research groups were able to
produce teratomas with all three germ layer derivatives
from canine ES cells [38] and iPS cells [15,16]. Lack of
teratoma formation raise a question about pluripotency
of these cell lines. In our study, ES and iPS cells are
pluripotent by this criterion. Both types of the cells
form morphologically monolayer colonies. In mouse and
human pluripotent stem cells, this morphology is char-
acteristic of primed pluripotent state. However, the mor-
phology of mink ES and iPS cells is very similar to that
of mink blastocyst inner cell mass [26]. This characteris-
tic could be species-specific and does not point out a
pluripotent state.
Expression of pluripotency-associated genes was
assessed based on transcriptome data showing that both
mink ES and iPS cells represent one cell type. Moreover,
we observed expression of several known key pluripo-
tency genes, including Rex1 (Figure 2b), which is consid-
ered a marker of naïve pluripotent state [40]. One
notable exception is the lack of Nanog expression as
only several copies of its transcript were found in soli-
tary replicates of pluripotent cell lines. This finding was
also verified by qPCR. Taking into consideration the
proven pluripotency of analyzed cell lines, we presume
that the low level of Nanog expression is a species-speci-
fic feature. Interestingly, Gata6 is expressed in all four
pluripotent cell lines. Gata6 is Nanog’s antagonist in
mouse early embryo development, Nanog-positive cells
tend to form epiblast while Gata6-positive - primitive
endoderm [41]. Thus, coexpression of Rex1 and Nanog
could be considered contradictory.
We have also analyzed the expression of several genes
such as Cer1 [42] and Otx2 [43] that are characteristic
of mouse primed pluripotent cells (Figure 2b). We can
observe the differences in these genes expression
between the different ES cell lines as well as when com-
pared to the iPS cell lines. Interestingly, the comparative
levels of Oct4, Sox2 and Rex1 expression in MES12 and
MES29 are reciprocal to Cer1 and Otx2. It might point
out to different pluripotent states of these ES cell lines.
Nevertheless, based on these gene expression levels we
cannot assess the pluripotent state of the analyzed cell
lines. It was shown that in mouse these genes are
expressed both in ES and epiblast stem cells but on dif-
ferent levels [42,44]. Due to the fact that we do not
have a control with known pluripotency status the
expression itself is not an indicator.
Table 3 Percentage of different categories of genes in mink iPS cells.
Correctly reprogrammed Intermediate pattern Not reprogrammed “Novel” pattern
iNV7 2569 (80.26%) 213 (6.65%) 239 (7.47%) 180 (5.62%)
iNV11 2579 (80.57%) 223 (6.97%) 224 (7.00%) 175 (5.47%)
Shared between iNV7 and iNV11 2232 (69.73%) 105 (3.28%) 90 (2.81%) 66 (2.06%)
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As it was shown for various mouse pluripotent cell
lines, addition of 2i could shift primed cells into naïve
[33,34]. Interestingly, to produce and culture canine
pluripotent cells investigators used supplementation
with substantially different factors, e.g. LIF as used for
mouse ES cells with bFGF as for human ES cells
[12,14,15,38]. In addition, some groups were able to
obtain pluripotent cells using 2i + LIF + bFGF [16] and
LIF + bFGF + 2i + valproic acid + TGH-b antagonist
A83-01 [11]. Some researchers used mix of all men-
tioned factors for iPS cell production but cultured iPS
cells with LIF only [13]. To test whether the change of
culture condition could change morphology of mink iPS
colonies we applied various combinations: 2i, (2i + LIF),
(2i + bFGF) and (2i + LIF + bFGF) respectively to
iNV11 cells for two weeks. The morphology of the colo-
nies remained unchanged. If mink iPS cells are in
primed pluripotent state, it maybe that additional factors
are needed to shift it to naïve. Alternatively, they could
already be in naïve state as indicated by Rex1 expression.
Conclusions
We produced and characterized American mink ES and
iPS cells. These cell lines have diploid chromosome
number, and are pluripotent based on teratoma forma-
tion test. The transcriptome analysis shows efficient
reprogramming of the mink EF genome to the pluripo-
tent state in iPS cells. Colony morphology and expres-
sion of several marker genes are not enough to
conclude whether the cells are in naïve or primed pluri-
potent state. We have found that Nanog is nearly absent
in these pluripotent stem cells and consider it as spe-
cies-specific feature.
Methods
Production of mink embryonic fibroblasts
Primary EF of American mink were obtained from indi-
vidual 29-day embryos by standard protocol [45]. Mink
of wild type genotype were used as donors of embryos.
The EF culture medium consisted of DMEM (Invitro-
gen, USA) supplemented with 10% fetal bovine serum
(Invitrogen, USA), and 1x penicillin and streptomycin
(Invitrogen, USA).
Production of mink ES cell lines
To produce mink ES cells, the previously published pro-
tocol was followed [25]. Embryos were obtained from
Public Center “Fur-bearing and farm animals” of Federal
State Budget Scientific Institution “The Federal Research
Center Institute of Cytology and Genetics of Siberian
Branch of the Russian Academy of Sciences” (ICG SB
RAS), Novosibirsk, Russia. Briefly, embryos of standard
(wild type) genotypes at morula and early blastocyst
stage were plated on plastic dishes coated with 0.1%
gelatin on mitomycin C inactivated mink EF. Zona pelluci-
dae of embryos was previously removed by treatment in
0.5% pronase solution. Within a few days the embryos
attached to the feeder layer of EF and formed colonies of
morphologically homogeneous cells similar to the ICM
cells. These primary colonies were passaged by trypsiniza-
tion with 0.25% Trypsin-EDTA (Invitrogen, USA) on the
fresh feeder. ES cell culture medium contained a-
MEM (Invitrogen, USA) with 20% ES cell qualified
FBS (Invitrogen, USA), 1x NEAA (Invitrogen, USA), 1x
GlutaMAX (Invitrogen, USA), 0.1 mM b-mercap-
toethanol (Sigma, USA) and 1x Penicillin-Streptomycin
(Invitrogen, USA). For subsequent culture we used
15% ES cell qualified FBS.
Production of mink iPS cell lines
To produce iPS cells from the mink EF we used lentiviral
vectors LeGO (http://www.lentigo-vectors.de/vectors.
htm) with GFP and human reprogramming transcription
factors: OCT4, SOX2, C-MYC and KLF4, courtesy of Dr.
Sergei L. Kiselev. Lentiviruses were produced in Phoenix
cell line using Lipofectamine LTX (Invitrogen, USA)
according to manufacturer’s recommendations. Multipli-
city of infection was estimated as 4.8 using GFP lentiviral
vector. Mink EF (3 × 105 cells, 15 × 103 cells/cm2) plated
the day before were transduced with viruses containing
four reprogramming transcription factors and 4 µg/ml
Polybrene. Transduction was performed three consecu-
tive days, on second and third day with halved amount of
C-MYC lentivirus. Until day 10 the medium was changed
daily with addition of 1 mM valproic acid. On day
7 transduced cells were seeded onto 10 cm culture dishes
on feeder in ES cell culture medium. From days 13 to
20 colonies with mink ES cell-like morphology were
picked up and expanded. All cell cultures were main-
tained at 37°C and 5% CO2.
All animal studies were undertaken with prior
approval from Interinstitutional Bioethical Committee
of ICG SB RAS.
Cytogenetic analysis
Cytogenetic analysis for ES was carried out on passages
7-23 and for iPS cell lines on passages 4-6. Preparation
of metaphase chromosomes from ES cells was per-
formed as previously described with minor modifica-
tions: cells were treated with hypotonic solution (0.56%
KCl for 15 min) and after that fixated with methanol/
acetic acid (3:1) solution [46]. For each cell line an aver-
age of 30 metaphase plates were analyzed on Carl Zeiss
Axioscop 2 imaging microscope with CoolCube 1 CCD-
camera (Meta Sistems). Digital images were analyzed
using ISIS (In Situ Imaging System, MetaSystems
GmbH) software in collective Microscopic Center of
ICG SB RAS, Novosibirsk, Russia.
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Immunofluorescence analysis of X-chromosome
inactivation
Immunofluorescence analysis was carried out according
to previously published protocol [47]. In short, cells cul-
tured on glass coverslips were fixed with 3% formalde-
hyde (Fluka, Germany) and permeabilized with 0.1%
Triton X-100 (Fluka, Germany). Non-specific binding
was blocked with 2% bovine serum albumin (Sigma,
USA) and cells were incubated with rabbit polyclonal or
anti-H3K27me3 antibodies (1:500) (Molecular Probes,
USA). The primary antibodies were visualized with the
secondary goat anti-rabbit IgG antibodies conjugated
with Alexa Fluor 488 (1:400) (Molecular Probes, USA).
The cells were stained with DAPI, mounted in a glycerol
solution containing 1,4 diazobicyclo-[2.2.3] octane
(DABCO) (Sigma, USA) and visualized on LSM 780
NLO (Zeiss) based on AxioObserver Z1 (Zeiss) using
ZEN software in collective Microscopic Center of ICG
SB RAS, Novosibirsk.
Teratoma formation analysis
For teratoma formation, we used SCID hairless outbred
mice (Crl:SHO-PrkdcscidHrhr) of SPF status and BALB/
c-nu. Experiments with SCID mice were performed in
the Center for Genetic Resources of Laboratory Animals
(RFMEFI61914X0005) at ICG SB RAS; BALB/c-nu mice
were kept in the Vivarium for conventional animals at ICG
SB RAS. Teratomas were produced using standard proto-
col [45]. Between 3 and 17.7 × 106 ES cells on passages
7-23 and 1.5 to 7 × 106 iPS cells on passages 5-14 were
injected subcutaneously into immunodeficient mice. Tera-
tomas generated by ES or iPS cells were dissected after
3-12 weeks and were fixed in Bouin solution. Paraffin sec-
tions were prepared according to standard protocol and
were stained with histological dyes Picro-Mallory trichro-
mica (04-021822), Masson trichromica (04-011802), P.T.A.
H.-hematoxyline (04-060802), Luxol fast blue Krever
Barrera (04-200812), Azan trichromica (04-001802), Picro-
fuchsin Van Gizon (04-030802) (Bio-Optica Milano S.P.A.,
Italy) and with hematoxylin-eosin. Images were analyzed
on Carl Zeiss Axioscop 2+ microscope with AxioCam HRc
CCD-camera. Digital images were taken using AxioVision
software in collective Microscopic Center of ICG SB RAS.
All animal studies were undertaken with prior
approval from Interinstitutional Bioethical Committee of
ICG SB RAS.
RNA isolation and cDNA synthesis
RNA was isolated from each sample using TriReagent®
(MRC Inc., USA) according to manufacturer’s recommen-
dations. We had three technical replicates for each cell
line (a, b and c, resulting in 15 samples in total). Genomic
DNA was removed using RNeasy MinElute Cleanup kit
(Qiagen, Germany). Quantity and quality were assessed in
a Nanodrop ND-1000 machine (Thermo Scientific). The
RNA integrity was assessed by gel electrophoresis and by
an Experion system (BioRad Laboratories) using the
ExperionTM RNA StdSens analysis kit (BioRad, Sweden).
Average RNA quality indicator values (RQI) were 9.7 for
the American mink ES cells, 9.6 for iPS cells and 9.3 for
EF. This RNA was used for RNAseq library preparation
and for cDNA synthesis, gene silencing analysis and qPCR.
One microgram of DNase I treated total RNA was
used for cDNA synthesis [48]. cDNA synthesis was
done in duplicates for each RNA sample, thus resulting
in 30 samples. All samples were diluted eight times
before using in qPCR.
Primer design
We used Primer3Plus software to design primers for the
following mink genes (Additional file 3): Sox2, Oct4, Gdf3,
Nanog and Nestin. For the reference genes Gapdh and
Hprt1 mink-specific primers were from Rouvinen-Watt
et al. [49].
Human-specific primers for C-MYC and KLF4 were
from Mathew et al. [50]. For OCT4 and SOX2 primer
design was based on the maximum number of mismatches
between human and mink sequences.
qPCR
qPCR was performed as described by Cirera et al. [51].
Briefly, PCR efficiency was calculated from the log-linear
portion of the standard curve for each assay, which was
done with dilution serials of a pool of cDNA from all
the samples to test. Efficiencies between 80 and 110%
were accepted. GeneEx Professional (MultiD) software
was used for pre-processing the qPCR data. Normalisa-
tion was undertaken using the two stable reference
genes according to GeNorm and NormFinder software
[52,53], namely GAPDH and HPRT1. Subsequently,
technical replicates were averaged and relative quantities
(fold changes, FC) were calculated based in the less
expressed sample for each assay. Prior to statistical ana-
lysis, FC were log2 transformed to ensure normal distri-
bution. Transcriptional differences between cell lines
were evaluated using analysis of variance (ANOVA). A
post hoc test (Tukey-Kramer) was performed in order
to see which pairwise comparisons were significant. P
values below 0.05 were considered significant. Results
are reported as mean of the Log2 of the FC. The qPCR
experiments, as well as the data analysis, were all com-
pliant with MIQE guidelines [54].
RNA-Seq data processing, reference assembly and
alignment
Prior to library preparation the RNA quality and integrity
was assessed according to Illumina guidelines. Library
preparation was done using the TruSeq® Stranded
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mRNA sample preparation 96 rxn kit (Illumina™) fol-
lowing the low sample protocol according to manufac-
turer’s recommendations. Briefly, approximately 2.5 µg of
total RNA was diluted and purified using RNA purifica-
tion beads targeting the poly-A tail of the mRNA and
subsequently was fragmented by means of the enzymes
provided in the kit. After the cDNA synthesis adenylation
of 3’ ends and ligation of the adaptors were performed.
Adaptors were ligated in 12-plex formations, allowing the
pooling of 12 samples after the PCR enrichment of the
library. Subsequently, the library was quantified using
PicoGreen® dye (Life Technologies™) as described in the
manufacturer’s protocol. Thereafter 12 samples were
pooled at equal concentrations to create the eight pools.
In order to accurately quantify the concentration in nM
of our pools, the Kapa SYBR® FAST universal qPCR kit
(Kapa Biosystems™) for Illunima™ sequencing was used
to quantify the number of the amplifiable molecules in
the pools and the Bioanalyzer® machine (Agilent Tech-
nologies™) to determine the average fragment size of the
pools. These measurements allowed optimizing the flow
cell clustering and proceed with the Run. The samples
were sequenced in five lanes of an Illumina HiSeq2000
sequencer, for 50 bp pair-end read.
Since mink pluripotent cells were maintained on
mouse feeder cells raw reads produced by next genera-
tion sequencing might contain transcripts of mouse fee-
der origin. Considering this, we aligned all data
produced from iPS and ES cells sequencing to mm10-
based mouse transcriptome (obtained from Illumina
iGenomes project, https://support.illumina.com/sequen-
cing/sequencing_software/igenome.html) using bowtie2
with parameters “–no-unal –no-sq –no-hd –np 0 –rdg
5,1 –rfg 5,1 –score-min L,-6.1,0 -X 500 –mp 3,2”. All
concordantly aligned read-pairs were considered as of
mouse origin and eliminated from the analysis.
We used filtered data from mink iPS and ES cells as
well as raw data from mink fibroblasts to perform
de novo transcriptome assembly. Transcriptome was
assembled using Trinity [55] with default parameters. We
blasted Trinity-produced data against mouse transcripts
and manually checked all highly similar (similarity >=
97%) sequences to ensure absence of contamination.
Annotation of de novo assembled contigs was done by
alignment coding sequences against the human RefSeq
mRNA database (Homo Sapiens GRCh37.66.cdna; http://
www.ensembl.org/Homo_sapiens). The contigs that did
not aligned against the human RefSeq were then blasted
against the Mustela putorius furo protein sequences
(Ensemble Genes 81; http://www.ensembl.org/info/data/
ftp/). The annotation was made only for sequences trans-
lating to minimum of 50 amino acids in length. For effi-
cient assembly, analysis and annotation of the data, scripts
developed in-house and described earlier were used [56].
To perform differential expression we used mouse-fil-
tered mink iPS and ES cells data. To make it compar-
able with fibroblasts data we also performed filtering of
fibroblasts reads aligning it to mouse transcriptome as
described above.
Resulting filtered sequencing data was aligned to the
transcriptome assembly using bowtie [57] with options
“-aS -X 800 –offrate 1”. Produced alignment results
were passed to the eXpress software [58] to obtain bias-
corrected counts. To analyze expression on gene-level
counts of all contigs representing the same gene were
summed using self-made python script. Obtained counts
were analyzed using DESeq2 package, that included
library size normalization, dispersions estimation, differ-
ential expression tests etc. [59].
Availability of supporting data
The raw sequenced data sets supporting the results of this
article are available in the NCBI BioProject repository,
http://www.ncbi.nlm.nih.gov/bioproject/297393.
Additional material
Additional file 1: Mink EF and MES25 stained with H3K27me3
antibodies and visualized with the secondary antibodies
conjugated with Alexa Fluor 488, counterstained with DAPI. a - mink
EF; b - MES25. (Additional file 1.jpg)
Additional file 2: Histological analysis of individual teratomas formed
after injection of ES and iPS cells into immunodeficient mice.
Additional file 3: Primers for qPCR and RT-PCR.
Additional file 4: qPCR raw data of selected gene expression.
Additional file 5: qPCR data of selected gene expression corrected by
PCR efficiency and normalized to reference genes Gapdh and Hprt1.
Additional file 6: P values of the pairwise comparison (Tukey-Kramer
post-test) of selected gene expression.
Additional file 7: Number of pair-end reads and base in mink cell lines.
Additional file 8: Lists of differentially expressed genes between mink
EF, ES and iPS cells.
Additional file 9: Expression levels of selected pluripotency-
associated genes in mink EF, ES and iPS cells. Vertical axis represents
counts determined for each sample by transcriptome analysis.
Additional file 10: Expression levels of shared between iNV7 and
iNV11 genes with “novel” expression pattern in EF, ES and iPS cells.
Vertical axis represents counts determined for each sample by
transcriptome analysis.
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